Abstract:Rheumatoid Arthritis (RA) stands as an intricate autoimmune inflammatory ailment, inciting joint inflammation and emerging as the most prevalent variant of inflammatory arthritis, impacting approximately 0.5% to 1% of the global populace. [ 1 , 2 ] Its occurrence registers 2 to 3 times higher among women in comparison to men. [ 3 ] Familial factors contribute to the condition in 40% to 65% of seropositive patients and 20% of seronegative patients. [ 4 ] The 2010 edition of RA diagnostic criteria comprises 4 facets: joint engagement, serological anomalies ascertained through RFs and ACPAs assessments, heightened indicators of acute inflammatory response, and arthritis duration. [ 5 ] Notably, RF measurements usually yield negative results in early RA. [ 6 ] Similarly, the ACPAs test exhibits low sensitivity in RA diagnosis. [ 7 ] Consequently, the novel RA classification criteria exhibit their imperfections as well, underscoring the significance of identifying novel serological biomarkers with substantial clinical utility to enhance RA diagnosis. In terms of treatment, non-steroidal anti-inflammatory drugs, glucocorticoids, and disease-modifying anti-rheumatic drugs represent commonplace interventions for RA. However, they often accompany side effects and demonstrate limited efficacy. [ 8 , 9 ] Although the precise etiology of RA remains elusive, it is generally attributed to a blend of epigenetic alterations, immune dysregulation, and environmental influences. [ 10 ] DNA methylation emerges as the quintessential epigenetic modification in humans, intimately linked with immune dysregulation. [ 11–13 ] Furthermore, RA-related DNA methylation patterns exhibit site-specific variances linked to immune pathways. [ 14 ] Recognizing the potential reversibility of epigenetic alterations, probing epigenetic malfunctions in autoimmune disorders has the capacity to uncover novel biomarkers and innovative therapeutic targets. Bibliometric analysis, a systematic and quantitative technique for scrutinizing scientific literature, assumes a pivotal role in research endeavors. It expedites the comprehension of epigenetic trends within rheumatoid arthritis, facilitating the identification of eminent authors and prolific research institutions, while swiftly pinpointing high-confidence, compelling research areas. [ 15 ] Herein, we undertake a visual analysis and synthesis of DNA methylation trends in rheumatoid arthritis, offering insights into the role of DNA methylation in the mechanisms, diagnostics, and treatments of this condition.

Epigenetic Regulation in the Pathogenesis of Rheumatoid Arthritis

Epigenetic Regulation Mediated by Methylation in the Pathogenesis and Precision Medicine of Rheumatoid Arthritis

Epigenetic Regulation of Immune and Inflammatory Responses in Rheumatoid Arthritis

The Mechanisms Underlying Chronic Inflammation in Rheumatoid Arthritis from the Perspective of the Epigenetic Landscape

Rheumatoid arthritis: pathogenesis and therapeutic advances

DNA Methylation of T Lymphocytes as a Therapeutic Target: Implications for Rheumatoid Arthritis Etiology

MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis

Epidermal growth factor receptor (EGFR) as a therapeutic target in rheumatoid arthritis

Genetics, epigenetics and autoimmunity constitute a Bermuda triangle for the pathogenesis of rheumatoid arthritis

Global research trends in DNA methylation in rheumatoid arthritis: A bibliometric analysis and visual analysis

Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis

Overview of mechanisms and novel therapies on rheumatoid arthritis from a cellular perspective

Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies

LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation

The Role of Resveratrol on Rheumatoid Arthritis: from Bench to Bedside

The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis

Assessing the potential of epigenetic targets as biomarkers in the diagnosis and treatment of rheumatoid arthritis

Epigenetic Regulation Mediated by Mirna in the Susceptibility and Pathogenesis of Rheumatoid Arthritis

Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies

M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics

Regulatory Role of the RNA N6-Methyladenosine Modification in Immunoregulatory Cells and Immune-Related Bone Homeostasis Associated With Rheumatoid Arthritis